Correlation Between Inozyme Pharma and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Elevation Oncology, you can compare the effects of market volatilities on Inozyme Pharma and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Elevation Oncology.
Diversification Opportunities for Inozyme Pharma and Elevation Oncology
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Elevation is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Elevation Oncology go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Elevation Oncology
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.52 times less risky than Elevation Oncology. The stock trades about -0.06 of its potential returns per unit of risk. The Elevation Oncology is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 256.00 in Elevation Oncology on November 9, 2024 and sell it today you would lose (189.00) from holding Elevation Oncology or give up 73.83% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Elevation Oncology
Performance |
Timeline |
Inozyme Pharma |
Elevation Oncology |
Inozyme Pharma and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Elevation Oncology
The main advantage of trading using opposite Inozyme Pharma and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |